Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ceapro Inc
V.CZO
Alternate Symbol(s):
CRPOF
Chemicals
Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human...
, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CZO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(43)
•••
Alex1726
X
View Profile
View Bullboard History
Post by
Alex1726
on Apr 25, 2024 9:01pm
What a mess.
How an incompetent guy like Gagnon has found a way to manage a company. He is a total useless , any guy that has a minimum of dignity and pride would try to do all he can to make things works , would
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:24pm
@ the Bell: Tech drop takes a bite out of the TSX
Technology shares led the decliners as the sector endured its worst day in more than a month on the TSX, dragged down by crypto miners.
read article.
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Apr 25, 2024 9:53am
New bear market
The S&P Biotech ETF is now down 21.22% in about 2 months sending it into a new bear market on interest rate and inflation concerns. With the US election this year fast approaching how could this
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 25, 2024 4:58am
Buzz on the Bullboards: A recap of recent activity and stocks in focus
After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.
read article.
(1941)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Apr 24, 2024 4:01pm
RE:2023 and Q4 results?????
Deadline April 29 for venture co.s. I thought Gagnon wanted to play with the Nasdaq big boys. Nasdaq deadline was March 31.
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Apr 24, 2024 3:47pm
2023 and Q4 results?????
Any one know when is the latest they can go on reporting the 2023 and q4 results?
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Apr 19, 2024 8:23am
Immune booster or longCOVID treatment anyone?
So many in Britain are sick GP's are writing so many sick notes it is destroying the finances of the nation and the Prime Minister is seeking to block sick notes and instead
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Apr 18, 2024 7:22pm
Avenanthramide and starch digestion
This study provides the first demonstration of the significant inhibitory effect of avenanthramides on starch digestion. Reduced starch digestibility helps to reduce calorie intake and prevents
...more
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Apr 17, 2024 2:59pm
RE:Bloom Burton - UGH...
Did you give him a piece of your mind? I wish I could be in the same room as Gagnon...
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Apr 17, 2024 1:33pm
RE:Bloom Burton - UGH...
"Gagnon presented the same old, tired dog and pony show yesterday to, no doubt..." I don't know that CZO has even presented. While CZO was listed as a presenting company there was no
...more
(88)
•••
PBaelishh
X
View Profile
View Bullboard History
Post by
PBaelishh
on Apr 17, 2024 12:42pm
Bloom Burton - UGH...
Mumbles Gagnon presented the same old, tired dog and pony show yesterday to, no doubt, a bunch of new people who were unaware of the truth & history of his pathetic tenure. Thing is, not one
...more
(88)
•••
PBaelishh
X
View Profile
View Bullboard History
Comment by
PBaelishh
on Apr 14, 2024 11:07am
RE:RE:RE:RE:RE:C$40 million market cap
Only recurring costs now for zero value are the parasites... Gagnon, Miller, et. al.
(15)
•••
pibopibopibopib
X
View Profile
View Bullboard History
Comment by
pibopibopibopib
on Apr 14, 2024 9:01am
RE:RE:RE:RE:C$40 million market cap
Thanks Isfca ! Isn't cheap Fortunately no recurrent.
(1941)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Apr 14, 2024 12:55am
RE:RE:RE:C$40 million market cap
CZO spent $1.5M to Sept 30/23 \...then add... 4 (d) To reflect the payment of $2,766,181 estimated non-recurring incremental transaction costs of Ceapro, including banking, printing, legal and
...more
(15)
•••
pibopibopibopib
X
View Profile
View Bullboard History
Comment by
pibopibopibopib
on Apr 13, 2024 6:02pm
RE:RE:C$40 million market cap
Where do you take this price 8 millions ?
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Apr 13, 2024 12:24pm
RE:Interstitial macrophages are a focus of viral takeover...
CZO's PGX-YBG targets and reprograms macrophages. Can it effectively target and reprogram these macrophages away from inflammation and fibrosis?
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Apr 13, 2024 12:13pm
Interstitial macrophages are a focus of viral takeover...
Skip Nav Destination Article|April 10 2024 Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil